Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 36 (5) , 852-858
- https://doi.org/10.1038/ki.1989.271
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- IMPROVEMENT IN THE ERYTHROPOIESIS OF CHRONIC HAEMODIALYSIS PATIENTS WITH DESFERRIOXAMINEThe Lancet, 1988
- ALUMINIUM CHELATION THERAPY IN DIALYSIS PATIENTS: EVIDENCE FOR INHIBITION OF HAEMOGLOBIN SYNTHESIS BY LOW LEVELS OF ALUMINIUMThe Lancet, 1988
- Microcytic Anemia in Dialysis Patients: Reversible Marker of Aluminum ToxicityAmerican Journal of Kidney Diseases, 1987
- Clinical and Laboratory Features of Aluminum-Related Bone Disease: Differences Between Sporadic and “Epidemic” Forms of the SyndromeAmerican Journal of Kidney Diseases, 1985
- Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related OsteodystrophyAnnals of Internal Medicine, 1984
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984
- Reversal of Aluminum-Induced Hemodialysis Anemia by a Low-Aluminum DialysateNew England Journal of Medicine, 1982
- The Dialysis Encephalopathy SyndromeNew England Journal of Medicine, 1976
- Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.Journal of Clinical Investigation, 1975
- Ferrokinetics: a biologic model for plasma iron exchange in manJournal of Clinical Investigation, 1970